Jordan Shin

Jordan Shin, MD, Ph.D., FACC is the Senior Vice President of Clinical Development and Translational Science. Prior to joining Renovacor, Dr. Shin most recently served as Vice President of Medical Development at Lung Biotechnology/United Therapeutics where he developed small molecule, biologic and device therapies for rare disease populations, ranging from pre-clinical to global late-stage trials. Before transitioning to industry, Dr. Shin spent 16 years as a physician-scientist at Massachusetts General Hospital and Harvard Medical School. During his time at the MGH, Dr. Shin served as the Medical Director for the Mechanical Circulatory Support program as a specialist in Advanced Heart Failure and Transplant cardiology. His lab in the Cardiovascular Research Center at MGH used zebrafish to investigate the basic pathways of cardiovascular development, and the pathogenesis of pulmonary hypertension and cardiomyopathy and were supported by competitive awards from the AHA and NIH.

Dr. Shin received his graduate and medical degrees at the University of Alabama at Birmingham.